$LBRX 8-K SEC Filings

Filed On	Filing
15 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure NEW YORK, September 15, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the mu...
03 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
11 Aug 2026	8-K: Results of Operations and Financial Condition
29 Jul 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
22 Jul 2026	8-K: Other Events
10 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
09 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
12 May 2026	8-K: Results of Operations and Financial Condition
26 Mar 2026	8-K: Results of Operations and Financial Condition
16 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
10 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
05 Feb 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
13 Nov 2025	8-K: Entry into a Material Definitive Agreement
12 Nov 2025	8-K: Other Events
06 Nov 2025	8-K: Results of Operations and Financial Condition
12 Sep 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year

Comments